Experimental cancer drug shows promise. The drug, geranylgeranyltransferase inhibitor GGTI-2418 suppresses a new defective PTEN cancer pathway, researchers have discovered. Source 8q.
Sponsored Links:
Post Date:Thu Nov 28 7:44:48 GMT 2024 / Post ID: #
Comment
Geranylgeranyltransferase Inhibitor Ggti-2418
In my opinion geranylgeranyltransferase inhibitor ggti2418 should be expanded briskly for us to get get down to the truth for geranylgeranyltransferase inhibitor ggti2418.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,